Your session is about to expire
← Back to Search
Corticosteroid
Treatment for Chronic Sinusitis
Phase 2 & 3
Waitlist Available
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
All Individual Drugs Already Approved
No Placebo-Only Group
Summary
This study is intended to assess the impact of a 90 day course of high volume budesonide irrigations for patients who have failed other medical therapy and assessing the impact of the budesonide irrigations on the need for sinus surgery.
Eligible Conditions
- Chronic Sinusitis
- Chronic Sinus Infection
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
SinoNasal Outcome Test (SNOT 22)
Side effects data
From 2016 Phase 4 trial • 222 Patients • NCT020553529%
Nasopharyngitis
9%
Influenza
8%
Headache
7%
Dysphonia
6%
Urinary tract infection
6%
Arthralgia
5%
Back pain
2%
Chronic obstructive pulmonary disease
1%
Peripheral arterial occlusive disease
1%
Vascular insufficiency
1%
Venous thrombosis limb
1%
Acute myocardial infarction
1%
Cor pulmonale
1%
Nodal arrhythmia
1%
Pneumonia
1%
Hip fracture
1%
Hepatocellular carcinoma
1%
Acute pulmonary oedema
1%
Bradycardia
1%
Cellulitis
100%
80%
60%
40%
20%
0%
Study treatment Arm
Fluticasone / Salmeterol (B)
Budesonide / Indacaterol (A)
Awards & Highlights
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
This is the group of enrollees who receive budesonide
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Budesonide
FDA approved
Find a Location
Who is running the clinical trial?
Kaiser PermanenteLead Sponsor
552 Previous Clinical Trials
27,702,257 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger